Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Diabetes

  • News

    Dapagliflozin meets primary endpoint in the DAPA-HF trial

    August 21, 2019

    AstraZeneca announces preliminary results in first heart failure trial in an SGLT2 inhibitor.

  • 1
    News

    FDA approves Baqsimi nasal powder for emergency hypoglycemia treatment

    July 25, 2019

    It is the first glucagon therapy approved for this indication that is administrable without an injection.

  • 1
    News

    FDA issues warning on insulin pump cybersecurity weakness

    June 28, 2019

    The MiniMed 508 and MiniMed Paradigm series insulin pumps are being recalled because of potential cybersecurity risks; 4,000 patients in the United States are affected.

  • 1
    News

    Aspirin shows little benefit for primary prevention of vascular disease in diabetes

    May 15, 2019

    Is aspirin for primary prevention of cardiovascular events in patients with diabetes worth the risk of adverse bleeding events?

  • 1
    News

    SGLT2 inhibitors prevent HF hospitalization regardless of baseline LVEF

    May 9, 2019

    NEW ORLEANS – “At least in my mind, we have more than enough evidence at this point to say that SGLT2 inhibitors are effective in preventing heart failure,” Dr. Mikhail Kosiborod said.

  • News

    Newer antihyperglycemic drugs have distinctive CV, kidney benefits

    March 12, 2019

    SGLT2 inhibitors and GLP-1 RAs have different effects on cardiovascular and kidney disease outcomes in patients with type 2 diabetes.

  • 1
    News

    ICU admissions raise chronic condition risk

    February 27, 2019

    Compared to non-ICU visitors, patients had greater risk of developing new chronic conditions after discharge.

  • 1
    News

    SGLT2 inhibitors morph into HF drugs

    February 7, 2019

    “We’re increasingly moving to an age where these agents are actually cardiovascular drugs that happen to lower blood glucose.” – Dr. Akshay S. Desai

  • 1
    News

    Intensive insulin added no benefit for hyperglycemia after ischemic stroke

    February 7, 2019

    Results from a large RCT showed intensive and standard insulin regimens produced similar clinical outcomes after an acute ischemic stroke.

  • 1
    News

    Metformin associated with acidosis only in patients with eGFR 30 mL/min per 1.73 m 2

    January 17, 2019

    Does metformin increase the risk of lactic acidosis in chronic kidney disease (CKD)?

Previous1 … 9 10 11 12 13 14Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
fa-facebookfa-linkedinfa-instagramfa-youtube-playfa-commentfa-envelopefa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences